BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9373276)

  • 1. High rates of hepatitis G virus infection in multitransfused patients with hemophilia.
    De Filippi F; Colombo M; Rumi MG; Tradati F; Prati D; Zanella A; Mannucci PM
    Blood; 1997 Dec; 90(11):4634-7. PubMed ID: 9373276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection with hepatitis G virus among recipients of plasma products.
    Jarvis LM; Davidson F; Hanley JP; Yap PL; Ludlam CA; Simmonds P
    Lancet; 1996 Nov; 348(9038):1352-5. PubMed ID: 8918279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis.
    Sheng L; Widyastuti A; Kosala H; Donck J; Vanrenterghem Y; Setijoso E; Soumillion A; Verslype C; Schelstraete R; Emonds MP; Hess G; Yap SH
    Am J Kidney Dis; 1998 Feb; 31(2):218-23. PubMed ID: 9469490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis G virus RNA and hepatitis G virus-E2 antibodies in Dutch hemophilia patients in relation to transfusion history.
    Mauser-Bunschoten EP; Damen M; Zaaijer HL; Sjerps M; Roosendaal G; Lelie PN; Cuypers HT; van den Berg HM
    Blood; 1998 Sep; 92(6):2164-8. PubMed ID: 9731076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor.
    De Filippi F; Castelli R; Cicardi M; Soffredini R; Rumi MG; Silini E; Mannucci PM; Colombo M
    Transfusion; 1998 Mar; 38(3):307-11. PubMed ID: 9563413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower hepatitis G virus infection prevalence compared to hepatitis B and C virus infection prevalences.
    Furusyo N; Hayashi J; Ariyama I; Sawayama Y; Etoh Y; Kashiwagi S
    Dig Dis Sci; 2000 Jan; 45(1):188-95. PubMed ID: 10695634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA and those with GBV-C/HGV E2-antibody in patients with hemophilia.
    Toyoda H; Takahashi I; Fukuda Y; Hayakawa T; Takamatsu J
    J Med Virol; 2000 Jan; 60(1):34-8. PubMed ID: 10568760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis G virus RNA in a monocentric population of French haemophiliacs.
    Gerolami V; Halfon P; Chambost H; Sicardi F; Thuret I; Planells R; Halimi G; Fossat C; Michel G; Cartouzou G
    Br J Haematol; 1997 Oct; 99(1):209-14. PubMed ID: 9359526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis.
    Tanaka E; Kiyosawa K; Shimoda K; Hino K; Tacke M; Schmolke S; Engel AM; Hess G
    J Viral Hepat; 1998 May; 5(3):153-9. PubMed ID: 9658367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
    Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
    J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.
    Yu ML; Chuang WL; Dai CY; Lu SN; Wang JH; Huang JF; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
    J Infect; 2001 Jan; 42(1):61-6. PubMed ID: 11243756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa.
    Sathar MA; Soni PN; Naicker S; Conradie J; Lockhat F; Gouws E
    J Med Virol; 1999 Sep; 59(1):38-44. PubMed ID: 10440806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors.
    Nordbø SA; Krokstad S; Winge P; Skjeldestad FE; Dalen AB
    J Clin Microbiol; 2000 Jul; 38(7):2584-90. PubMed ID: 10878048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and infectivity of hepatitis G virus and its strain variant, the GB agent, in volunteer blood donors in Taiwan.
    Wang JT; Chen PJ; Liu DP; Sheu JC; Wang TH; Chen DS
    Transfusion; 1998 Mar; 38(3):290-5. PubMed ID: 9563410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TT virus and hepatitis G virus infections in Korean blood donors and patients with chronic liver disease.
    Jeon MJ; Shin JH; Suh SP; Lim YC; Ryang DW
    World J Gastroenterol; 2003 Apr; 9(4):741-4. PubMed ID: 12679923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus.
    Tan D; Matsumoto A; Conry-Cantilena C; Melpolder JC; Shih JW; Leuther M; Hess G; Gibble JW; Ness PM; Alter HJ
    J Infect Dis; 1999 May; 179(5):1055-61. PubMed ID: 10191204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
    Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
    N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C and G virus infection and liver dysfunction after allogeneic bone marrow transplantation: results from a prospective study.
    Rodriguez-Iñigo E; Tomás JF; Gómez-García de Soria V; Bartolomé J; Pinilla I; Amaro MJ; Carreño V; Fernández-Rañada JM
    Blood; 1997 Aug; 90(3):1326-31. PubMed ID: 9242569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.